Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.19M Buy
527,034
+5,964
+1% +$65.4K ﹤0.01% 2184
2025
Q4
$3.89M Buy
521,070
+6,687
+1% +$52.9K ﹤0.01% 2610
2025
Q3
$4.02M Sell
514,383
-3,579
-0.7% -$26.3K ﹤0.01% 2592
2025
Q2
$3.77M Buy
517,962
+2,907
+0.6% +$18.4K ﹤0.01% 2563
2025
Q1
$3.6M Buy
515,055
+21,531
+4% +$179K ﹤0.01% 2544
2024
Q4
$4.24M Buy
493,524
+148,784
+43% +$1.13M ﹤0.01% 2473
2024
Q3
$2.52M Sell
344,740
-74,149
-18% -$615K ﹤0.01% 2793
2024
Q2
$4.14M Buy
418,889
+323,096
+337% +$3.45M ﹤0.01% 2450
2024
Q1
$1.27M Buy
95,793
+20,408
+27% +$242K ﹤0.01% 3074
2023
Q4
$1.03M Sell
75,385
-11,496
-13% -$152K ﹤0.01% 3179
2023
Q3
$1.32M Sell
86,881
-775
-0.9% -$14.3K ﹤0.01% 3020
2023
Q2
$2.3M Sell
87,656
-18,402
-17% -$406K ﹤0.01% 2806
2023
Q1
$2.2M Sell
106,058
-29,901
-22% -$449K ﹤0.01% 2803
2022
Q4
$1.4M Sell
135,959
-1,608
-1% -$14.9K ﹤0.01% 2969
2022
Q3
$1.05M Sell
137,567
-4,218
-3% -$34.6K ﹤0.01% 3091
2022
Q2
$967K Sell
141,785
-9,891
-7% -$78.1K ﹤0.01% 3137
2022
Q1
$1.63M Buy
151,676
+33,381
+28% +$366K ﹤0.01% 3006
2021
Q4
$1.5M Buy
118,295
+108,195
+1,071% +$1.4M ﹤0.01% 3070
2021
Q3
$116K Buy
+10,100
New +$134K ﹤0.01% 3770

Other funds holding INTT

Ameriprise's INTT Position: Q1 2026 in Review

Ameriprise increased its inTEST (INTT) stake by 1.1% in Q1 2026, buying an estimated $65.4K and bringing the position to 527,034 shares worth $7.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2184.

Ameriprise first reported a position in INTT in Q3 2021 and has held it in 19 quarters since. 75 funds tracked by Wall St. Rank hold INTT as of Q1 2026.

  • Ameriprise held 527,034 shares of inTEST worth $7.19M as of Q1 2026.
  • Ameriprise bought 5,964 inTEST shares in Q1 2026, an estimated $65.4K.
  • inTEST made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2184 holding.
  • Ameriprise first reported a position in inTEST in Q3 2021 and has held it in 19 quarters since.
  • 75 funds tracked by Wall St. Rank held inTEST as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.